TB
Theravance Biopharma Inc (TBPH)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$16.87
-0.15%
Mkt Cap $871.23M
Analyst Ratings
Buy
5
Hold
6
Sell
0
Price Target (7 analysts)
$27.00
Range $14.00 – $40.00
Implied Upside
+60.1%
Consensus $27.00 vs current $16.87